Institute for International Research

Know how to achieve

Main menu

My IIR

Login form

Sign Up

Registration

Online Registration is open!

Customer Service

Have a question about this event?
Customer Service representatives are available to help from 8 AM - 6 PM EST
Call 888-670-8200



Need Technical Assistance With this Website?
Send an email to IIR's Web Department

Find another IIR Event

Event Search Form by Industry

Home»Events»4th Annual Sarbanes-Oxley...Conference Documentation

4th Annual Sarbanes-Oxley Compliance for the Pharmaceutical and Biotech

November 29 - 30, 2007 | Courtyard by the Marriott Downtown Philadelphia, Philadelphia, PA

Conference Documentation

Conference Documentation

This page will be used to provide paid delegates of the conference with access to any presentations that were not included in the conference documentation. Only paid conference delegates have permission to access IIR online documentation.

While these presentations were not available to be included in your conference documentation, IIR is pleased to make them available to all conference delegates through this web site.

You will need the freely available Adobe Acrobat Reader, which is available by clicking here


SEC Update on New Guidelines: Improving Sarbanes-Oxley Section 404 Implementation
Josh K. Jones, Professional Accounting Fellow, Office of the Chief Accountant, SECURITIES AND EXCHANGE COMMISSION

PCAOB Update on New Guidelines: A Risk Based Approach for Auditors
Greg Fletcher, Associate Chief Auditor, PUBLIC COMPANY ACCOUNTING OVERSIGHT BOARD (PCAOB)

Sarbanes-Oxley and FIN 48: Their First Implications with the IRS
Kurt Meier, Director of Field Operations – Retailers, Food, Pharmaceuticals and Healthcare, INTERNAL REVENUE SERVICE

An Integrated Approach to Governance, Risk, and Compliance
Lee Dittmar, Principal, DELOITTE CONSULTING LLP

Case Study: Pfizer's Approach to SOX Compliance: Identifying Risk and the Appropriate Controls
Ray Purcell, Director, Financial Controls, PFIZER INC.

INTERACTIVE LEARNING SESSION: Sarbanes-Oxley for Small Pharmaceutical and Biotech Companies: What Does it Take to Implement Sarbanes-Oxley in an Organization and Increase Efficiency
Tonja Grönneröd, Sarbanes Oxley Project Manager, GPC BIOTECH INC.

You've Implemented Sarbanes-Oxley…Now What? The Next Steps to Maintaining Compliance & Increasing Efficiencies Under New Guidance
Peter Agnoletto, Senior Director, Internal Audit, PAR PHARMACEUTICALS COMPANIES, INC.

The Detection and Prevention of Problems of Non-Compliant Behavior- Save Your Company From Potentially Costly Mistakes
Jay Dubow, Partner, PEPPER HAMILTON LLP

Six Sigma and SOX: Developing the Process to Ensure it is Well Controlled
Susan S. Cifelli, CPA, Manager Process Excellence, Corp Finance, JOHNSON & JOHNSON

Manage Your Partnership with An Outside Auditor for a Streamlined the SOX Process and Increase Productivity
Tamara Candler, CPA, SOX Coordinator, ELI LILLY & COMPANY;
Diane Hoff, Partner, Ernst & Young

Information Partners

  • PharmaVOICE

  • BioWorld Today

Information Support

  • Deloitte

Event Sponsor

  • SAP

Send To A Friend

Invite a colleague to join you at this event

Add Event To Calendar

Save the event dates in your Outlook calendar

Bottom menu

Copyright 2003-2006 IIR Holdings, Ltd. All rights Reserved

Powered by Interactive Agency Janmedia Interactive, Inc.